These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

888 related articles for article (PubMed ID: 9015760)

  • 1. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor.
    Perez M; Haschke B; Donato NJ
    Oncogene; 1999 Jan; 18(4):967-78. PubMed ID: 10023672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X; Weng LP; Yu Q
    Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein tyrosine phosphatase LAR has a major impact on insulin receptor dephosphorylation.
    Mooney RA; Kulas DT; Bleyle LA; Novak JS
    Biochem Biophys Res Commun; 1997 Jun; 235(3):709-12. PubMed ID: 9207225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
    Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
    J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling.
    Kroder G; Bossenmaier B; Kellerer M; Capp E; Stoyanov B; Mühlhöfer A; Berti L; Horikoshi H; Ullrich A; Häring H
    J Clin Invest; 1996 Mar; 97(6):1471-7. PubMed ID: 8617880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors.
    Mishra S; Mathur R; Hamburger AW
    Lymphokine Cytokine Res; 1994 Apr; 13(2):77-83. PubMed ID: 8061118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase regulation in fibroblasts from patients with an insulin receptor gene mutation.
    Seki N; Yagi S; Suzuki Y; Shimada F; Taira M; Makino H; Amano K; Yagui K; Saito Y; Hashimoto N
    Horm Metab Res; 2008 Dec; 40(12):833-7. PubMed ID: 18925540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell density-dependent changes in the insulin action pathway: evidence for involvement of protein-tyrosine phosphatases.
    Li PM; Goldstein BJ
    J Cell Biochem; 1996 Apr; 61(1):31-8. PubMed ID: 8726353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
    Donato NJ; Rosenblum MG; Steck PA
    Cell Growth Differ; 1992 May; 3(5):259-68. PubMed ID: 1378752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PI 3-kinase and SH-PTP2 in insulin action.
    Kasuga M
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S87-9. PubMed ID: 8894489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH; Fleming IN; Downes CP
    Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha: a continuum of liability between insulin-dependent diabetes mellitus, non-insulin-dependent diabetes mellitus and carcinoma (review).
    Holden RJ; Pakula IS; Mooney PA
    Med Hypotheses; 1999 Apr; 52(4):319-23. PubMed ID: 10465670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells.
    Suárez Pestana E; Tenev T; Gross S; Stoyanov B; Ogata M; Böhmer FD
    Oncogene; 1999 Jul; 18(28):4069-79. PubMed ID: 10435588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells.
    Li PM; Zhang WR; Goldstein BJ
    Cell Signal; 1996 Nov; 8(7):467-73. PubMed ID: 9023010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
    Ross SA; Lienhard GE; Lavan BE
    Biochem Biophys Res Commun; 1998 Jun; 247(2):487-92. PubMed ID: 9642156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intracellular Ca2+ in the epidermal growth factor induced inhibition of protein tyrosine phosphatase activity in a breast cancer cell line.
    Mishra S; Hamburger AW
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1066-72. PubMed ID: 7682060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing Src homology 2 regions and modulates its PTPase activity in vitro.
    Maegawa H; Ugi S; Adachi M; Hinoda Y; Kikkawa R; Yachi A; Shigeta Y; Kashiwagi A
    Biochem Biophys Res Commun; 1994 Mar; 199(2):780-5. PubMed ID: 8135823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.